In mouse models of AD, reversing CREB deficiency decreases Aβ and p-tau231 and mitigates neuroinflammation, ultimately leading to increased synaptic plasticity and cognitive function (Rong et al., 2025). This evidence concerns the gene CREB1 and Alzheimer disease.